GlassScriptPhysician profile
Ibrahim Wiah Adamu
NPI 1013238245
$2,897.71
in general payments reported to CMS, 2019-2025
12 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $227 · 2021: $80.98 · 2022: $105 · 2023: $121 · 2024: $29.71 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $750 · Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $750.00 |
| Food and Beverage | $289.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,579.32 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $65.95 | 2022-2025 | Phasix Mesh |
| Allergan, INC. | $62.37 | 2021-2022 | |
| Baxter Healthcare | $36.75 | 2023-2024 | Seprafilm, Perclot |
| Ethicon US, LLC | $30.47 | 2019 | |
| Boston Scientific Corporation | $23.57 | 2025 | Spyglass Discover |
| Abbott Laboratories | $21.80 | 2025 | Eterna |
| Phathom Pharmaceuticals, INC. | $19.95 | 2025 | Voquezna |
| Convatec INC. | $15.63 | 2022 | |
| Abbvie INC. | $14.80 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Conmed Corporation | $14.63 | 2025 | Airseal, Visiclear |
| Thd America, INC. | $12.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Adamu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.